Floatz logo

su011248

Ciliary Body and Choroid Melanoma, Medium/Large Size

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Ciliary Body and Choroid Melanoma, Medium/Large Size cohort.

Asset / SponsorPhaseRating
Tyrosinase Peptide
National Cancer Institute (NCI)
Phase 3BB
FLUTICASONE
National Cancer Institute (NCI)
Phase 3BB
Sargramostim
National Cancer Institute (NCI)
Phase 3BB
FILGRASTIM
National Cancer Institute (NCI)
Phase 3BB
Ifa
National Cancer Institute (NCI)
Phase 2B

View all 29 →

Same molecule, other indications

su011248 is also rated in:

Gastrointestinal Stromal TumorsDormant
BBB
Indicative ·
75 / 100
View asset →
Pancreatic Neuroendocrine TumorDormant
BB
Indicative ·
69 / 100
View asset →
Renal Cell CarcinomaDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →